The control of tauopathy in Alzheimer's disease. Diagnostic and therapeutic aspects

Listen to audio

In his seminar, Étienne-Émile Baulieu described the role of hyper-phosphorylation of the protein tau, located inside neurons, and its contribution to the development of Alzheimer's disease. The regulation of tau activity by small-scale effectors was envisaged, opening up a potential new therapeutic avenue.

The control of tauopathy in Alzheimer's disease. Diagnostic and therapeutic aspects

Speaker(s)

Étienne-Émile Baulieu

Events

Faced with bacteria resistant to conventional drugs, what do we have?

Antibiotic resistance : an emerging disease

Tropical diseases : diseases that bring in little. Cases of malaria and bilharzia

Phenotypic and genotypic mechanisms involved in Plasmodium resistance to artemisinins

Drug activation by cytochromes : good or bad?

Could we now discover clopidogrel and its precursor ticlopidine, two major antiplatelet and antithro…

Viral diseases : what tools are needed to combat new pathogenic viruses?

Dendrimers and their therapeutic uses : innovative nanomedicine

Tuberculosis : mechanism of isoniazid action

Recent developments in the treatment of resistant tuberculosis and AIDS

Cancer treatments : old and new approaches

Personalized cancer treatments : realities and prospects

Gene therapies : hopes and realities

Cellular reprogramming and neural phenotype instability : fundamental and ethical aspec…

When will we have effective treatments for Alzheimer's disease ?

The control of tauopathy in Alzheimer's disease. Diagnostic and therapeutic aspects

See also